Article
SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A
21 Feb 2015
Abstract excerpt
Lung cancer has been the most prolific cancer in China - as in the rest of the world - with a high death rate and low 5-year survival rate. Previous evidence showed that JMJD2A is over-expressed in human non-small cell lung cancer (NSCLC) tissues compared to adjacent normal tissues, and that high level of JMJD2A predicts poor overall and disease-free survival. However, the mechanism by which JMJD2A is regulated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
